InvestorsHub Logo
Followers 44
Posts 2816
Boards Moderated 0
Alias Born 08/15/2013

Re: kingbee post# 109382

Saturday, 04/09/2022 3:28:21 PM

Saturday, April 09, 2022 3:28:21 PM

Post# of 113752
Damage is done, harsh and sobering review of what transpired.....

"Matters like these can certainly be confusing. However, this story is a good reminder of the importance of reading the fine print when it comes to filing news. All that happened today was that Sunshine Biopharma confirmed its S3 resale went into effect — not a new filing or resale announcement.

While there was no real reason for investors to panic today, the performance we’ve seen from SBFM stock still raises some questions regarding its future. The company’s recent cancer treatment success pushed it out of penny stock territory. For the past one month, shares are in the green by more than 330%.

Why It Matters

When a stock rises overnight by such a high amount, its gains inevitably stabilize. That’s likely what we’re seeing from SBFM stock. It’s easy for a pharmaceutical company to rise quickly on positive results. However, shares are often just as quick to fall as the momentum subsides. This is especially true for small caps that weren’t previously on Wall Street’s radar.

Today’s performance indicates that SBFM stock likely isn’t the play some investors might have hoped. If it was truly stable, this news wouldn’t have forced it down by so much. Sunshine is also likely not a meme stock favorite, as investor confidence has clearly been shaken. All told, this seems like a flash-in-the-pan spike from a company about to fall back below the $5 mark."

From Investor Place

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News